Biological E. Limited is a leading pharmaceutical company based in India. Established in 1953, the company has grown to become a key player in the global healthcare industry.

Headquartered in Hyderabad, India, Biological E. Limited operates from a state-of-the-art manufacturing facility spread over 100 acres. The facility is equipped with cutting-edge technology and adheres to stringent quality and safety standards.

The company's headquarters also house a dedicated research and development center where a team of highly skilled scientists work to develop innovative products. The main products and services offered by Biological E. Limited include vaccines, biosimilars, branded generics, and pharmaceutical formulations.

The company specializes in vaccines for diseases such as diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae, among others. They also manufacture biosimilars for conditions like rheumatoid arthritis and anemia. With a strong focus on research and development, Biological E.

Limited constantly endeavors to introduce new and improved healthcare solutions. On a global scale, Biological E. Limited has established a strong presence through partnerships, joint ventures, and subsidiaries.

They have collaborated with renowned international organizations such as the World Health Organization (WHO) and the Gates Foundation to address global healthcare challenges. The company has also entered into strategic alliances with key pharmaceutical companies to widen its product range and geographical reach. In terms of market position, Biological E.

Limited has carved a niche for itself in the healthcare industry. The company's commitment to quality and innovation has earned it a reputation as a trusted provider of healthcare products. With a strong global sales network, Biological E.

Limited competes with major pharmaceutical companies and is known for its consistent growth and success. In terms of major events and achievements, Biological E. Limited has received several accolades for its contribution to the healthcare sector.

They have been recognized by the WHO for their efforts in expanding access to vaccines and improving immunization coverage globally. This underlines the company's dedication to making a positive impact on public health. As of the latest available information, Biological E.

Limited continues to strengthen its position as a leading pharmaceutical company. They strive to meet the evolving needs of healthcare professionals and patients through the development and introduction of innovative healthcare solutions. With a focus on research and development, they continue to expand their product portfolio while maintaining their commitment to quality and patient safety